Jason Kim
President chez MOLECULAR TEMPLATES, INC.
Fortune : 14 260 $ au 31/03/2024
Profil
Jason S.
Kim's career history includes current positions as President, CFO, CAO & Treasurer at Molecular Templates, Inc. and Chief Operating Officer at Molecular Templates OpCo, Inc. He previously worked as Director-Business Development at ImClone LLC from 2003 to 2006, Director-Business & Corporate Development at OSI Pharmaceuticals, Inc. from 2009 to 2011, and as an Associate at Safeguard Scientifics, Inc. and Domain Associates LLC.
Additionally, he served as President & Chief Financial Officer at Molecular Templates, Inc. from 2010 to 2017.
Mr. Kim obtained an undergraduate degree from Wesleyan University and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/01/2024 | 6 366 ( 0,12% ) | 14 260 $ | 31/03/2024 |
Postes actifs de Jason Kim
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | President | 01/02/2010 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Operating Officer | - |
Anciens postes connus de Jason Kim
| Sociétés | Poste | Fin |
|---|---|---|
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Director of Finance/CFO | 01/08/2017 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2011 |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 01/01/2009 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2006 |
| SAFEGUARD SCIENTIFICS, INC. | Corporate Officer/Principal | - |
Formation de Jason Kim
| Wesleyan University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAFEGUARD SCIENTIFICS, INC. | Finance |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
